Catalyst Wire Dossier Catalyst Wire Dossier

SARS-CoV-2 specific T cells adoptive therapy

· KK Women’s and Children’s Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV-2 specific T cells adoptive therapy, covering 2020-07-07 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 [Phase 1, Phase 2]

See pricing